| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |